From Global Products to Individual Functionings: Medicinal Drugs in Developing Countries

Jeffrey James
Additional contact information
Jeffrey James: Tilburg University

Chapter 4 in Consumption, Globalization and Development, 2000, pp 61-84 from Palgrave Macmillan

Abstract: Abstract Previous chapters and indeed most of the existing literature on the welfare effects of new products in developing countries are based on a form of analysis (developed primarily by Lancaster) that focuses on the specific characteristics embodied in those products.1 Those combinations of characteristics are then evaluated from the point of view of their appropriateness to household groups differentiated, most frequently, by levels of income. Because they are mainly produced in developed countries, new products, so the argument usually runs, contain a high proportion of ‘high-income’ characteristics that make them unconducive to the satisfaction of basic needs in developing countries. Or, put another way, the conclusion is typically that new products tend to confer their benefits disproportionately on rich rather than poor consumers in developing countries.

Keywords: Drug Product; Drug Consumption; Welfare Effect; Global Product; Health Functionings (search for similar items in EconPapers)
Date: 2000
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:palchp:978-0-230-51095-1_4

Ordering information: This item can be ordered from
http://www.palgrave.com/9780230510951

DOI: 10.1057/9780230510951_4

Access Statistics for this chapter

More chapters in Palgrave Macmillan Books from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().